Vit C
PreclinicalSmall molecule
Vit C is one of 32 small molecule programs targeting Oxidative Stress. It is currently in Preclinical.
2
Indications
5
Total Trials
0
Active Trials
31
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
138 competitors in Oxidative Stress
#DrugCompanyPhaseTrials
1Kerendia
BayerPhase 3
Qvar
SSchering-Plough
Phase 3
Droxia
TTheravia
Phase 3
Deltavit
HHyundai Pharmaceutical Co., LTD.
Phase 3
Ascorbate
FFudan University
Phase 3
Niacin/laropiprant
Merck & Co.Phase 3
Pterostilbene
UUniversity of Mississippi Medical Center
Phase 3
Bayer Aspirin
BayerPreclinical
Nicorette
PfizerPreclinical
Tractocile
GSKPreclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Conditioning1 trial
Age1 trial
Comparative Evaluation of Vitamin C and Injectable-platelet Rich Fibrin in the Management of Thin Gingival Phenotype
Unknown status·—·Phase 4·NCT05841303·13 enrolled
Rickets1 trial
Effectiveness of Vitamin C Supplementation in Treatment of Rickets
Completed·—·Phase 2/3·NCT05310760·88 enrolled
Bacterial Infections1 trial
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Vit C. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- MMedical University of Vienna